Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
GLIS2 has emerged as a critical player in the pathogenesis of nephronophthisis, an autosomal recessive ciliopathy characterized by chronic tubulointerstitial nephritis, progressive renal failure, and a range of extrarenal manifestations (PMID:18607645). Several independent studies across diverse cohorts have investigated the genetic underpinnings of this disorder, consistently implicating GLIS2 in its etiology.
Genetic evidence is compelling. A case report detailed a consanguineous family in which a novel homozygous in-frame deletion, c.560_574delACCATGTCAACGATT (p.His188_Tyr192del) (PMID:34917135), segregated with nephronophthisis. This result is supported by multi‐patient exome sequencing studies that identified pathogenic mutations in GLIS2 among 32 families (PMID:26489029), underscoring a strong gene–disease association.
The variant spectrum for GLIS2 includes disruptions that affect key functional domains, particularly the zinc finger motifs essential for its role in transcriptional regulation. The reported in-frame deletion disrupts the alpha-helical structure within a zinc-finger domain, likely resulting in misfolding and loss of function consistent with the disease phenotype.
Functional studies further strengthen the association. Multiple assays have demonstrated that GLIS2 is essential for proper nuclear localization and transcriptional regulation. Experimental work shows that mutations in GLIS2 impair DNA binding and transactivation functions (PMID:21127075; PMID:26374130), and animal models of Glis2 deficiency recapitulate key features of nephronophthisis, including renal fibrosis and tubular atrophy.
Although some investigations have proposed potential roles for GLIS2 beyond classical ciliary function, the preponderance of evidence from segregation analyses, variant impact studies, and functional assays consistently supports a pathogenic mechanism rooted in altered transcriptional regulation.
In summary, the integration of robust genetic findings—including segregation in consanguineous families and identification of a disruptive in-frame deletion—with corroborative functional data confirms a strong association between GLIS2 and nephronophthisis. This evidence not only informs diagnostic decision‑making but also underscores the gene’s potential as a target for future therapeutic strategies.
Gene–Disease AssociationStrongThe association is supported by a homozygous mutation identified in 1 proband from a consanguineous family (PMID:34917135), along with confirmatory evidence from multi‐patient exome sequencing across 32 families (PMID:26489029) and consistent phenotypic observations in nephronophthisis (PMID:18607645). Genetic EvidenceStrongA novel homozygous in-frame deletion, c.560_574delACCATGTCAACGATT (p.His188_Tyr192del) (PMID:34917135), disrupts a critical zinc finger domain in GLIS2 with clear segregation in a consanguineous context and is corroborated by broader exome sequencing analyses. Functional EvidenceStrongMultiple functional assays demonstrate that GLIS2 is crucial for nuclear localization and transcriptional regulation; mutations impair DNA binding and lead to a nephronophthisis phenotype, as evidenced by studies in cellular and animal models (PMID:21127075; PMID:26374130). |